| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | C/O ANNEXON, INC., 1400 SIERRA POINT PKWY, BLDG C, STE 200, BRISBANE | /s/ Jennifer Lew, Attorney-in-Fact | 04 Mar 2026 | 0001958523 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANNX | Common Stock | Sale | $32,004 | -5,894 | -3.2% | $5.43 | 180,093 | 02 Mar 2026 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). |
| F2 | This transaction was executed in multiple trades in prices ranging from $5.35 to $5.56, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |